---
Journal of Clinical Apheresis, Ahead of Print. (Source: Journal of Clinical Apheresis)
Source: Journal of Clinical Apheresis - January 26, 2018 Category: Hematology Source Type: research
Issue Information
Journal of Clinical Apheresis,Volume 33, Issue 1, Page 1-4, February 2018. (Source: Journal of Clinical Apheresis)
Source: Journal of Clinical Apheresis - January 25, 2018 Category: Hematology Source Type: research
---
Journal of Clinical Apheresis,Volume 33, Issue 1, Page 1-4, February 2018. (Source: Journal of Clinical Apheresis)
Source: Journal of Clinical Apheresis - January 25, 2018 Category: Hematology Source Type: research
Issue Information
(Source: Journal of Clinical Apheresis)
Source: Journal of Clinical Apheresis - January 25, 2018 Category: Hematology Tags: ISSUE INFORMATION Source Type: research
The impact of preapheresis white blood cell count on autologous peripheral blood stem cell collection efficiency and HSC infusion side effect rate
Journal of Clinical Apheresis, EarlyView. (Source: Journal of Clinical Apheresis)
Source: Journal of Clinical Apheresis - January 19, 2018 Category: Hematology Source Type: research
---
Journal of Clinical Apheresis, Ahead of Print. (Source: Journal of Clinical Apheresis)
Source: Journal of Clinical Apheresis - January 19, 2018 Category: Hematology Source Type: research
Successful treatment of rituximab ‐ and steroid‐resistant nephrotic syndrome with leukocytapheresis
Journal of Clinical Apheresis, EarlyView. (Source: Journal of Clinical Apheresis)
Source: Journal of Clinical Apheresis - January 16, 2018 Category: Hematology Source Type: research
---
Journal of Clinical Apheresis, Ahead of Print. (Source: Journal of Clinical Apheresis)
Source: Journal of Clinical Apheresis - January 16, 2018 Category: Hematology Source Type: research
Therapeutic plasma exchange for thrombotic thrombocytopenic purpura with refractory thrombocytopenia
Journal of Clinical Apheresis, EarlyView. (Source: Journal of Clinical Apheresis)
Source: Journal of Clinical Apheresis - December 22, 2017 Category: Hematology Source Type: research
---
Journal of Clinical Apheresis, Ahead of Print. (Source: Journal of Clinical Apheresis)
Source: Journal of Clinical Apheresis - December 22, 2017 Category: Hematology Source Type: research
Autograft immune effector cells and survival in autologous peripheral blood hematopoietic stem cell transplantation
Journal of Clinical Apheresis, EarlyView. (Source: Journal of Clinical Apheresis)
Source: Journal of Clinical Apheresis - December 12, 2017 Category: Hematology Source Type: research
---
Journal of Clinical Apheresis, Ahead of Print. (Source: Journal of Clinical Apheresis)
Source: Journal of Clinical Apheresis - December 12, 2017 Category: Hematology Source Type: research
The impact of preapheresis white blood cell count on autologous peripheral blood stem cell collection efficiency and HSC infusion side effect rate
ConclusionThis study has shown that preapheresis PB WBC and granulocyte counts were associated with leukapheresis CE. Additionally, the leukapheresis product TNC and granulocyte content was correlated with thawed graft infusion side effect occurrence. (Source: Journal of Clinical Apheresis)
Source: Journal of Clinical Apheresis - December 1, 2017 Category: Hematology Authors: Araci. M. Sakashita, Andrea T. Kondo, Ana Paula H. Yokoyama, Sanny M. C. Lira, Carolina B. Bub, Aline M. Souza, Andrea N. F. Cipolletta, Kelen C. Alvarez, Nelson Hamerschlak, Jose M. Kutner, Carlos S. Chiattone Tags: RESEARCH ARTICLE Source Type: research
Successful treatment of rituximab ‐ and steroid‐resistant nephrotic syndrome with leukocytapheresis
We report the case of a patient with RTX‐resistant nephrotic syndrome and SRNS who was successfully treated with leukocytapheresis (LCAP). After LCAP, there was a significant reduction in proteinuria and in the total number of lymphocytes, T cells, and HLA‐DR+‐activated T cells. Moreover, the patient became sensitive to steroids and RTX. LCAP reduced circulating immune cells including activated T cells and could be effective in treating rituximab‐resistant nephrotic syndrome and SRNS and in achieving remission of proteinuria. (Source: Journal of Clinical Apheresis)
Source: Journal of Clinical Apheresis - December 1, 2017 Category: Hematology Authors: Maiko Takakura, Masaki Shimizu, Mao Mizuta, Natsumi Inoue, Yuko Tasaki, Kazuhide Ohta, Kengo Furuichi, Takashi Wada, Akihiro Yachie Tags: BRIEF REPORT Source Type: research
Therapeutic plasma exchange for thrombotic thrombocytopenic purpura with refractory thrombocytopenia
Thrombotic thrombocytopenic purpura (TTP) is an acute, life‐threatening illness with disseminated platelet‐rich thromboses of small vessels that variably presents with the classic clinical “pentad” of microangiopathic hemolytic anemia, thrombocytopenia, fever, altered mental status, and acute kidney injury. Most cases are caused by an acquired autoantibody to ADAMTS13, a metalloproteinase that cleaves large von Willebrand Factor (vWF) multimers. The mainstay of treatment is daily therapeutic plasma exchange (TPE), sometimes with adjunctive pharmacologic immunosuppression. TPE is generally continued until the platel...
Source: Journal of Clinical Apheresis - December 1, 2017 Category: Hematology Authors: Nolan Maloney, Isabella Martin, Zbigniew M. Szczepiorkowski, Nancy M. Dunbar Tags: CASE REPORT Source Type: research
